Analyses of ADAMTS13 activity and its inhibitor in patients with thrombotic thrombocytopenic purpura secondary to connective tissue diseases: Observation in a single hospital [3]

Clinical and Experimental Rheumatology

Volumn 24, Issue 4, 2006, Pages 454-455

  Sato, Takeo ^a,b   Hanaoka, R ^a   Ohshima, M ^a   Miwa, Y ^a   Okazaki, Y ^a   Yajima, N ^a   Ishizashi, H ^c   Matsumoto, M ^c   Fujimura, Y ^c   Inokuma, S ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DNA ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; LA ANTIBODY; METHYLPREDNISOLONE; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; PROTEINASE INHIBITOR; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SCL 70 ANTIBODY; VINCRISTINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; ANTIBODY DETECTION; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DEATH; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; GOODPASTURE SYNDROME; HUMAN; JAPAN; LETTER; MICROSCOPIC POLYANGIITIS; PLASMA TRANSFUSION; PLASMAPHERESIS; POLYMYOSITIS; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

ADAM PROTEINS; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; JAPAN; MIDDLE AGED; PROTEASE INHIBITORS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; VON WILLEBRAND FACTOR;

EID: 33748552315     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. MOSCHCOWITZ E: Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc N Y Pathol Soc 1924; 24: 21-4.
2. MOAKE JL: Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600.
3. FURLAN M, ROBLES R, GALBUSERA et al.: von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339:1578-84.
4. TSAI H-M, LIAN EC-Y: Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-94.
5. FESSLER BJ: Thrombotic syndromes and autoimmune diseases. Rheum Dis Clin North Am 1997; 23: 461-79.
6. FURLAN M, ROBLES R, SOLENTHALER M, LAMMLE B: Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic puipura. Blood 1998; 91: 2839-46.
7. KINOSHITA S, YOSHIOKA A, PARK YD et al.: Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura. Int J Hematol 2001; 74: 101-8.
8. MANNUCCI PM, VANOLI M, FORZA I, CANCIANI MT, SCORZA R: Von Willebrand factor cleaving protease (ADAMTS- 13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Haematologica 2003; 88: 914-8.
9. MATSUMOTO M, YAGI H, ISHIZASHI H, WADA H, FUJIMURA Y: The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Semin Hematol 2004; 41: 68-74.